ဤ E-စာအုပ်အကြောင်း
By focusing on general molecular mechanisms of antiviral drugs rather than therapies for individual viruses, this ready reference provides the critical knowledge needed to develop entirely novel therapeutics and to target new viruses.
It begins with a general discussion of antiviral strategies, followed by a broad survey of known viral targets, such as reverse transcriptases, proteases, neuraminidases, RNA polymerases, helicases and primases, as well as their known inhibitors. The final section contains several cases studies of recent successful antiviral drug development.
Edited by Erik de Clercq, the world authority on small molecule antiviral drugs, who has developed more new antivirals than anyone else.
It begins with a general discussion of antiviral strategies, followed by a broad survey of known viral targets, such as reverse transcriptases, proteases, neuraminidases, RNA polymerases, helicases and primases, as well as their known inhibitors. The final section contains several cases studies of recent successful antiviral drug development.
Edited by Erik de Clercq, the world authority on small molecule antiviral drugs, who has developed more new antivirals than anyone else.
စာရေးသူအကြောင်း
Erik De Clercq, M.D., PhD is currently President of the Rega Foundation, a member of the Belgian (Flemish) Royal Academy of Medicine and of the Academia Europaea, and a Fellow of the American Association for the Advancement of Science. He is an active Emeritus Professor of the Katholieke Universiteit Leuven (K.U.Leuven), Belgium. He is honorary doctor of the Universities of Ghent, Belgium, Athens, Greece, Ferrara, Italy, Jinan (Shandong), China, Charles (Prague), Czech Republic, and Jihoceska (Ceske Budejovice), Czech Republic, and Tours, France.
For his pioneering efforts in antiviral research, Professor De Clercq received in 1996 the Aventis award from the American Society for Microbiology, and in 2000 the Maisin Prize for Biomedical Sciences from the Belgian National Science Foundation. In 2008 he was elected Inventor of the Year by the European Union. Jointly with Dr. Anthony Fauci, Prof. De Clercq received the Dr. Paul Janssen Award for Biomedical Research in 2010.
He is the (co)inventor of a number of antiviral drugs, used for the treatment of HSV (valaciclovir, Valtrex , Zelitrex ), VZV (brivudin, Zostex , Brivirac , Zerpex ), CMV (cidofovir, Vistide ), HBV (adefovir dipivoxil, Hepsera ), and HIV infections (AIDS) (tenofovir disoproxil fumarate, Viread ).
For his pioneering efforts in antiviral research, Professor De Clercq received in 1996 the Aventis award from the American Society for Microbiology, and in 2000 the Maisin Prize for Biomedical Sciences from the Belgian National Science Foundation. In 2008 he was elected Inventor of the Year by the European Union. Jointly with Dr. Anthony Fauci, Prof. De Clercq received the Dr. Paul Janssen Award for Biomedical Research in 2010.
He is the (co)inventor of a number of antiviral drugs, used for the treatment of HSV (valaciclovir, Valtrex , Zelitrex ), VZV (brivudin, Zostex , Brivirac , Zerpex ), CMV (cidofovir, Vistide ), HBV (adefovir dipivoxil, Hepsera ), and HIV infections (AIDS) (tenofovir disoproxil fumarate, Viread ).
ဤ E-စာအုပ်ကို အဆင့်သတ်မှတ်ပါ
သင့်အမြင်ကို ပြောပြပါ။
သတင်းအချက်အလက် ဖတ်နေသည်
စမတ်ဖုန်းများနှင့် တက်ဘလက်များ
Android နှင့် iPad/iPhone တို့အတွက် Google Play Books အက်ပ် ကို ထည့်သွင်းပါ။ ၎င်းသည် သင့်အကောင့်နှင့် အလိုအလျောက် စင့်ခ်လုပ်ပေးပြီး နေရာမရွေး အွန်လိုင်းတွင်ဖြစ်စေ သို့မဟုတ် အော့ဖ်လိုင်းတွင်ဖြစ်စေ ဖတ်ရှုခွင့်ရရှိစေပါသည်။
လက်တော့ပ်များနှင့် ကွန်ပျူတာများ
Google Play မှတစ်ဆင့် ဝယ်ယူထားသော အော်ဒီယိုစာအုပ်များအား သင့်ကွန်ပျူတာ၏ ဝဘ်ဘရောင်ဇာကို အသုံးပြု၍ နားဆင်နိုင်ပါသည်။
eReaders နှင့် အခြားကိရိယာများ
Kobo eReader များကဲ့သို့ e-ink စက်ပစ္စည်းပေါ်တွင် ဖတ်ရှုရန် ဖိုင်ကို ဒေါင်းလုဒ်လုပ်ပြီး သင့်စက်ထဲသို့ လွှဲပြောင်းပေးရမည်။ ထောက်ပံ့ထားသည့် eReader များသို့ ဖိုင်များကို လွှဲပြောင်းရန် ကူညီရေးဌာန အသေးစိတ် ညွှန်ကြားချက်များအတိုင်း လုပ်ဆောင်ပါ။
